Predictive factors for the effectiveness of novel androgen receptor axis‐targeted agents in patients with metastatic prostate cancer-Reference-Cited by-同舟云学术

Predictive factors for the effectiveness of novel androgen receptor axis‐targeted agents in patients with metastatic prostate cancer

Published:2022-09-07 Issue:12 Volume:29 Page:1477-1487
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J of Urology

Author:

Koshiro Nishimoto¹^ORCID,Nakajima Kenichi²^ORCID,Oyama Masafumi¹,Kaneko Go¹,Takahashi Satoru³^ORCID,Matsuyama Hideyasu⁴,Shiina Hiroaki⁵,Ichikawa Tomohiko⁶,Horikoshi Hiroyuki⁷,Hashine Katsuyoshi⁸^ORCID,Sugiyama Yutaka⁹,Miyao Takeshi¹⁰,Kamiyama Manabu¹¹,Harada Kenichi¹²^ORCID,Ito Akito¹³^ORCID,Mizokami Atsushi¹⁴,

Affiliation:

1. Department of Uro‐Oncology Saitama Medical University International Medical Center Saitama Japan

2. Department of Functional Imaging and Artificial Intelligence Kanazawa University Graduate School of Medical Science Kanazawa Japan

3. Department of Urology Nihon University School of Medicine Tokyo Japan

4. Department of Urology, Graduate School of Medicine Yamaguchi University Ube Japan

5. Department of Urology Shimane University Faculty of Medicine Shimane Japan

6. Department of Urology, Graduate School of Medicine Chiba University Chiba Japan

7. Department of Diagnostic Radiology Gunma Prefectural Cancer Center Ota Japan

8. Department of Urology National Hospital Organization Shikoku Cancer Center Matsuyama Japan

9. Department of Urology, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan

10. Department of Urology Gunma University Graduate School of Medicine Maebashi Japan

11. Department of Urology University of Yamanashi Yamanashi Japan

12. Division of Urology, Department of Surgery Related Kobe University Graduate School of Medicine Kobe Japan

13. Department of Urology Iwate Medical University Iwate Japan

14. Department of Integrative Cancer Therapy and Urology Kanazawa University Graduate School of Medical Science Kanazawa Japan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.15022

Reference21 articles.

1. Global cancer statistics, 2012

2. Overcoming Persistent Dependency on Androgen Signaling after Progression to Castration-Resistant Prostate Cancer: Fig. 1.

3. Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial

4. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

5. Abiraterone and Increased Survival in Metastatic Prostate Cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initial-to-nadir Prostate-specific Antigen Ratio Predicts Response to First-line Enzalutamide in Metastatic Castration-resistant Prostate Cancer;Anticancer Research;2023-09-29